Immunotherapy

AAD: Subcutaneous Amlitelimab Aids Atopic Dermatitis Outcomes Through Week 24

Physician’s Briefing

AAD: Subcutaneous Amlitelimab Aids Atopic Dermatitis Outcomes Through Week 24

08 Apr 2026

2 min read

AAD: Ixekizumab + Tirzepatide Boosts Psoriatic Arthritis Outcomes More Than Ixekizumab Monotherapy

Physician’s Briefing

AAD: Ixekizumab + Tirzepatide Boosts Psoriatic Arthritis Outcomes More Than Ixekizumab Monotherapy

06 Apr 2026

2 min read

Addition of Atezolizumab to mFOLFOX6 Ups DFS in Stage III dMMR Colon Cancer

Physician’s Briefing

Addition of Atezolizumab to mFOLFOX6 Ups DFS in Stage III dMMR Colon Cancer

03 Apr 2026

1 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com